Join a powerful, unprecedented alliance for better eye health for all.
Join IAPB-
Choose an alternate language here
The World Health Assembly adopted a resolution on improving the transparency of markets for medicines, vaccines and other health products in an effort to expand access.
The resolution urges Member States to enhance public sharing of information on actual prices paid by governments and other buyers for health products, and greater transparency on pharmaceutical patents, clinical trial results and other determinants of pricing along the value chain from laboratory to patient.
It requests the WHO secretariat to support efforts towards transparency and monitor the impact of transparency on affordability and availability of health products, including the effect of differential pricing.
The aim is to help Member States to make more informed decisions when purchasing health products, negotiate more affordable prices and ultimately expand access to health products for the populations.
Assuring access to medicines is key to advancing universal health coverage. Member States also expressed wide support for the WHO Access Roadmap for Medicines, Vaccines and other health products, which will determine WHO’s work on this issue for the next five years.
Click here for the original article on the WHO website.
Image on top: Giving Trachoma MDA(AZT syrup) by Solomon Gadisa
Benedictine Eye Hospital innovates eye care solutions through integration of renewable energy in thier services
Vanuatu has been validated by the World Health Organization (WHO) for eliminating trachoma as a public health problem.
Call for application for a Consultancy on Eye Health in WHO AFRO.
The WHO Global Coordination Mechanism on NCDs (GCM/NCD) is launching the first cycle of the Noncommunicable Disease Lab.
A new focus on learning for impact and building competencies to make the world a healthier place. This is the thinking behind the World Health Organization’s new WHO Academy
